Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK8 | P45983 | 1/20 | 0.37 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.37 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | KDM4C | Q9H3R0 | 4/20 | 0.33 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | MPO | P05164 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetone SCHEMBL44217 | 0.96 | MAPK8 (0.37) | MAPK8MAPK9MAPK10CA12CA1 | |
| Acetone SCHEMBL16337583 | 0.95 | MAPK8 (0.36) | MAPK8MAPK9MAPK10CA12CA1 | |
| Hydrochloric Acid SCHEMBL14954478 | 0.74 | ALDH1A1 (0.39) | KDM4EALDH1A1TDP1 | |
| SCHEMBL6512756 | 0.74 | ALDH1A1 (0.43) | KDM4EALDH1A1GLAGAACYP1A2 | |
| Acetone SCHEMBL538074 | 0.73 | ALDH1A1 (0.40) | KDM4EALDH1A1TDP1 | |
| SCHEMBL6762577 | 0.72 | ALDH1A1 (0.51) | KDM4EALDH1A1GAASIRT3TDP1 | |
| Hydrazine SCHEMBL2725095 | 0.72 | ALDH1A1 (0.48) | KDM4EALDH1A1GAASIRT3TDP1 | |
| SCHEMBL4073078 | 0.72 | TP53 (0.50) | KDM4EALDH1A1GLAGAASIRT3 | |
| SCHEMBL4352598 | 0.71 | KDM4E (0.55) | MAPK10KDM4EALDH1A1GLAGAA | |
| SCHEMBL5580002 | 0.71 | NNMT (0.36) | KDM4EGAATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE50754-E1 | Compositions and method for multiplex biomarker profiling | THE UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2026-01-20 | — | — | US | disclosed |
| US-RE50555-E1 | Compositions and method for multiplex biomarker profiling | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2025-08-26 | — | — | US | disclosed |
| US-12332239-B2 | Magnetic removal or identification of damaged or compromised cells or cellular structures | INGURAN, LLC (US) | 2025-06-17 | — | — | US | disclosed |
| US-20250109449-A1 | HIGH THROUGHPUT NUCLEIC ACID SEQUENCING BY EXPANSION | ROCHE SEQUENCING SOLUTIONS INC (US) | 2025-04-03 | — | — | US | disclosed |
| US-20240254475-A1 | PROTEOMIC ANALYSIS WITH NUCLEIC ACID IDENTIFIERS | THE BROAD INSTITUTE, INC. | 2024-08-01 | — | — | US | disclosed |
| WO-2022117731-A9 | ELECTROSTATIC NANOPARTICLES AND USE THEREOF | Westfälische Wilhelms-Universität Münster (DE) | 2024-05-16 | — | — | WO | disclosed |
| US-20240091315-A1 | XTEN CONJUGATE COMPOSITIONS AND METHODS OF MAKING SAME | AMUNIX PHARMACEUTICALS, INC. | 2024-03-21 | — | — | US | disclosed |
| US-20240024500-A1 | ELECTROSTATIC NANOPARTICLES AND USE THEREOF | UNIVERSITÄT MÜNSTER (DE) | 2024-01-25 | — | — | US | disclosed |
| US-11873483-B2 | Proteomic analysis with nucleic acid identifiers | THE BROAD INSTITUTE, INC. (US) | 2024-01-16 | — | — | US | disclosed |
| US-20230384302-A1 | MAGNETIC REMOVAL OR IDENTIFICATION OF DAMAGED OR COMPROMISED CELLS OR CELLULAR STRUCTURES | INGURAN, LLC (US) | 2023-11-30 | — | — | US | disclosed |
| US-11630108-B2 | Cell processing using magnetic particles | INGURAN, LLC (US) | 2023-04-18 | — | — | US | disclosed |
| US-11549135-B2 | Oligonucleotide-coupled antibodies for single cell or single complex protein measurements | THE BROAD INSTITUTE, INC. (US) | 2023-01-10 | — | — | US | disclosed |
| US-11531026-B2 | Magnetic removal or identification of damaged or compromised cells or cellular structures | INGURAN, LLC (US) | 2022-12-20 | — | — | US | disclosed |
| US-RE49304-E1 | Compositions and method for multiplex biomarker profiling | UNIVERSITY OF WASHINGTON (US) | 2022-11-22 | — | — | US | disclosed |
| EP-3551766-B1 | INTEGRATED IMMUNO-PCR AND NUCLEIC ACID ANALYSIS IN AN AUTOMATED REACTION CARTRIDGE | CEPHEID (US) | 2022-09-14 | — | — | EP | disclosed |
| WO-2022117731-A1 | ELECTROSTATIC NANOPARTICLES AND USE THEREOF | Westfälische Wilhelms-Universität Münster (DE) | 2022-06-09 | — | — | WO | disclosed |
| EP-4006550-A1 | COMPOSITION FOR MAGNETIC REMOVAL OR IDENTIFICATION OF DAMAGED OR COMPROMISED CELLS OR CELLULAR STRUCTURES | Inguran, LLC (US) | 2022-06-01 | — | — | EP | disclosed |
| US-20220064741-A1 | HIGH THROUGHPUT NUCLEIC ACID SEQUENCING BY EXPANSION | Roche Sequencing Solutions, Inc. | 2022-03-03 | — | — | US | disclosed |
| EP-3563933-B1 | MAGNETIC REMOVAL OR IDENTIFICATION OF DAMAGED OR COMPROMISED CELLS OR CELLULAR STRUCTURES | INGURAN LLC (US) | 2022-03-02 | — | — | EP | disclosed |
| EP-2077113-A1 | Treatment of autoimmune diseases | Rheinische Friedrich-Wilhelms-Universität Bonn (DE) | 2009-07-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250109449-A1 | HIGH THROUGHPUT NUCLEIC ACID SEQUENCING BY EXPANSION | ERCC4, NUDT21, XPNPEP1 | MAPK8 2420/4885MAPK9 4282/4885MAPK10 4519/4885 |
| US-20240024500-A1 | ELECTROSTATIC NANOPARTICLES AND USE THEREOF | FCGRT, NCL, EEA1 | MAPK8 4395/4885MAPK9 2849/4885MAPK10 3720/4885 |
| US-20240091315-A1 | XTEN CONJUGATE COMPOSITIONS AND METHODS OF MAKING SAME | XPA, TXLNA, NGLY1 | MAPK8 3072/4885MAPK9 4280/4885MAPK10 2173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.